The Traderszone Network

Published in TZ Latest News 26 April, 2015 by The TZ Newswire Staff

Can You Guess Which State Won’t Pay for Hepatitis C Drugs?

One state decided to take a hard line stance against Gilead’s pricey hep C drugs last year. And this decision may end up turning into a huge windfall for AbbVie’s rival therapy. Here’s why.